Clinical Trial Update: Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial update on telotristat etiprate showing expanded treatment for patients with carcinoid syndrome symptoms; results completed with posted data in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• Telotristat Etiprate (telotristat etiprate)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Carcinoid Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-09-17